PCYT2
Ethanolamine-phosphate cytidylyltransferase
Also known as: ET, PCY2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99447
- Gene
- PCYT2
- Ensembl
- ENSG00000185813
- Chromosome
- 17
- Canonical length
- 389 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the formation of CDP-ethanolamine from CTP and phosphoethanolamine in the Kennedy pathway of phospholipid synthesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
389 residues, UniProt reviewed canonical sequence.
>Q99447|PCYT2
1 MIRNGRGAAG GAEQPGPGGR RAVRVWCDGC YDMVHYGHSN QLRQARAMGD YLIVGVHTDE
61 EIAKHKGPPV FTQEERYKMV QAIKWVDEVV PAAPYVTTLE TLDKYNCDFC VHGNDITLTV
121 DGRDTYEEVK QAGRYRECKR TQGVSTTDLV GRMLLVTKAH HSSQEMSSEY REYADSFGKC
181 PGGRNPWTGV SQFLQTSQKI IQFASGKEPQ PGETVIYVAG AFDLFHIGHV DFLEKVHRLA
241 ERPYIIAGLH FDQEVNHYKG KNYPIMNLHE RTLSVLACRY VSEVVIGAPY AVTAELLSHF
301 KVDLVCHGKT EIIPDRDGSD PYQEPKRRGI FRQIDSGSNL TTDLIVQRII TNRLEYEARN
361 QKKEAKELAF LEAARQQAAQ PLGERDGDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCYT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 249 nTPM
Expression across tissuesHPA
Tissue
- testis: 249 nTPM
- liver: 163 nTPM
- duodenum: 60 nTPM
- spinal cord: 48 nTPM
- cerebral cortex: 47 nTPM
- heart muscle: 45 nTPM
Single-cell type
- late spermatids: 5,103 nCPM
- late primary spermatocytes: 841 nCPM
- early spermatids: 730 nCPM
- hepatocytes: 156 nCPM
- breast lactating cells: 144 nCPM
- enterocytes: 131 nCPM
Immune cell
- naive B-cell: 5.6 nTPM
- memory CD4 T-cell: 5.5 nTPM
- memory CD8 T-cell: 4.7 nTPM
- naive CD8 T-cell: 4.7 nTPM
- gdT-cell: 4.6 nTPM
- myeloid DC: 4.6 nTPM
Brain region
- medulla oblongata: 53 nTPM
- pons: 53 nTPM
- cerebellum: 47 nTPM
- midbrain: 45 nTPM
- white matter: 45 nTPM
- spinal cord: 41 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PCYT2.
Disease | AllUniProt
Conditions PCYT2 is implicated in, by any mechanism.
- Spastic paraplegia 82, autosomal recessive (SPG82) MIM:618770
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 120 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spastic paraplegia 82, autosomal recessive
- Inborn genetic diseases
- Ovarian serous cystadenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.73
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ethanolamine-phosphate cytidylyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cytidyltransferase-like domain
- Rossmann-like alpha/beta/alpha sandwich fold
- CTP:phosphocholine cytidylyltransferase domain
- Cytidylyltransferase-like
- Ethanolamine-phosphate cytidylyltransferase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCYT2 as an antibody target. Whether an autoantibody or antibody against PCYT2 could matter depends on whether native PCYT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCYT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCYT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...